1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Interventions modified
Sixth Affiliated Hospital, Sun Yat-sen UniversityPhase 2/3 NCT06958432 Registry history of NCT06958432 on ClinicalTrials.gov (opens the registry)
Updated
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-09-22 | NCT07833332 Endoscopic Stricturotomy Versus Balloon Dilation for Small Bowel Fibrotic Strictures in… | Recruiting | |
| 2026-09-17 | NCT07824791 Prediction of Postoperative Recurrence in Crohn's Disease | Recruiting |
| Phase 1 | 1 | |
| Phase 1/2 | 1 | |
| Phase 2 | 21 | |
| Phase 2/3 | 3 | |
| Phase 3 | 10 | |
| Phase 4 | 4 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07510191 | TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With… | Crohn Disease (CD) | Recruiting | 2026-06-09 |
| NCT07216014 | Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety | Crohn's Disease and Ulcerative Colitis | Recruiting | 2026-04-24 |
| NCT06520397 | Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus… | Crohn Disease | Recruiting | 2026-02-23 |
| NCT05813860 | HLADQA1*05 Genotype and the Efficacy of Treatment With Infliximab in Chinese Population… | Crohn Disease | Not Yet Recruiting | 2023-05-09 |
| Phase 3 | ||||
| NCT07549399 | SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC | Rectal Adenocarcinoma | Recruiting | 2026-07-01 |
| NCT06998758 | Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally… | Neoadjuvant Chemotherapy | Recruiting | 2025-12-12 |
| NCT05797467 | Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal… | Colorectal Cancer | Recruiting | 2023-05-24 |
| NCT05815082 | ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer | Colorectal Cancer | Recruiting | 2023-04-18 |
| NCT05797077 | Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer… | Colorectal Cancer | Recruiting | 2023-04-04 |
| NCT07149467 | Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With… | Crohn's Disease Aggravated | Not Yet Recruiting | 2025-09-02 |
| NCT06760065 | Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and… | Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education | Not Yet Recruiting | 2025-01-09 |
| NCT05607927 | PE-Bacon for Late Complications of Chronic Radiation-induced Rectal Injury | Chronic Radiation Injury | Not Yet Recruiting | 2022-11-07 |
| NCT03961841 | Perioperative Combination Chemotherapy Versus Chemoradiation for Locally Advanced EGJ… | Esophagogastric Junction Disorder | Not Yet Recruiting | 2019-12-23 |
| NCT03975049 | Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for… | Rectal Cancer | Not Yet Recruiting | 2019-06-05 |
| Phase 2/3 | ||||
| NCT06958432 | Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for… | Rectal Cancer | Recruiting | 2026-09-28 |
| NCT06958419 | Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor… | Immune Checkpoint Therapy | Recruiting | 2025-08-07 |
| NCT07538284 | MInimizing Delirium With Nasal Dexmedetomidine-InducEd Sleep (MIDDIES) | Major Abdominal Surgery | Not Yet Recruiting | 2026-04-20 |
| Phase 2 | ||||
| NCT07808853 | Node-Sparing Short-Course Radiotherapy (25 Gy/5 Fractions) Combined With… | ESCC | Recruiting | 2026-09-09 |
| NCT06776016 | Dietary Supplements to Treat Radiation-Induced Rectal Injury | Radiotherapy | Recruiting | 2026-08-07 |
| NCT06510010 | Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of… | Chemotherapy Effect | Recruiting | 2026-08-06 |
| NCT04840264 | Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel… | Metastatic Gastric Adenocarcinoma | Recruiting | 2026-07-13 |
| NCT06364384 | Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic… | Rectal Squamous Cell Carcinoma | Recruiting | 2026-07-01 |
| NCT07669220 | A Multicenter, Randomized Controlled Phase II Study of Short-Course Radiotherapy Followed… | Rectal Adenocarcinoma | Recruiting | 2026-06-25 |
| NCT07176182 | Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB… | Rectal Cancer Patients | Recruiting | 2026-05-26 |
| NCT06002789 | Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC | Multiple Cancer | Recruiting | 2026-04-27 |
Colorectal Cancer (34) · Crohn's Disease (15) · Ulcerative Colitis (5) · Gastric Cancer (4) · Anxiety (1) · Breast Cancer (1) · Esophageal Cancer (1)